Acer Therapeutics, Inc.
(NASDAQ : ACER)

( )
ACER After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
MRKMerck & Co., Inc. -0.01%78.320.7%$1640.63m
JNJJohnson & Johnson 0.72%161.260.7%$1027.09m
PFEPfizer Inc. -0.38%41.510.9%$984.93m
ABBVAbbVie, Inc. 0.41%109.361.9%$719.23m
BMYBristol-Myers Squibb Co. 1.11%58.341.0%$691.66m
LLYEli Lilly & Co. 0.55%237.981.1%$629.67m
AZNAstraZeneca Plc 0.92%60.221.0%$377.08m
NVSNovartis AG 0.90%83.340.2%$177.37m
GSKGlaxoSmithKline Plc 0.75%39.010.2%$158.74m
RGENRepligen Corp. -0.61%266.926.8%$129.47m
AVIRAtea Pharmaceuticals, Inc. -2.89%39.280.3%$121.41m
CRVSCorvus Pharmaceuticals, Inc. -3.51%4.950.7%$109.87m
VTRSViatris, Inc. -0.15%13.460.0%$98.18m
NVONovo Nordisk A/S 1.89%102.340.1%$90.55m
RPRXRoyalty Pharma Plc 3.59%38.390.1%$87.06m

Company Profile

Acer Therapeutics, Inc. is a pharmaceutical company. It engages in the acquisition, development and commercialization of therapies for medical needs. Its product pipeline includes ACER-001 Edsivo and ACER-2820. The Edsivo is a type of celiprolol for Vascular Ehlers-Danlos syndrome. The ACER-001 is for the treatment of urea cycle disorders and Maple Syrup Urine diseases. The company was founded on March 15, 1991 and is headquartered in Newton, MA.